Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc. financial statements

Tvardi Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 18.21M10-K
Cash and equivalentsUSD 20.73M10-Q
Total debtUSD 201KEODHD

Tvardi Therapeutics, Inc. financials on 6ix · Tvardi Therapeutics, Inc. on 6ix